Glutamate transporters as therapeutic targets (part B)
The epithelial calcium channel TRPV6 promotes the progression of carcinomas, including those of breast and prostate. TRPV6 is thus an important target for cancer treatment. Also, the dysfunction of TRPV6 expressed in the intestine may lead to osteoporosis, suggesting another important therapeutic application.
University of Bern, Institute of Biochemistry and Molecular Medicine
|Hediger Matthias A. (PI)